JPRN-jRCT1020230002招募中Unknown
A Survey of Treatment Trends of Diabetic Macular Edema by Miyagi Medical Welfare Information Network - MMWIN study in DME patients
akazawa Toru0 个研究点目标入组 250 人开始时间: 2023年4月17日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •The research participants are a group of patients aged 18 years or older with center involved DME with central subfield thickness (CSFT) of at least 300 micro m or more in the study eye. The research participants are living in the northeastern part of Japan and who complete enrollment from January 2023 to May 2024.
- •Patients eligible for inclusion in this study have to meet all of the following criteria:
- •(1)Adults (18 years or older) with newly diagnosed DME (treatment naive)
- •(2)Patients expected to regularly visit the hospital for treatment for a year
- •(3)Patients who registered in MMWIN database or who have already registered in MMWIN database at the enrolement of this study
- •(4)Voluntary written consent
排除标准
- •Patients who do not meet any of the following criteria:
- •Patients with concurrent eye disease that may cause macular edema (Including choroidal neovascularization, retinal vein occlusion, uveitis, and recent intraocular surgery of any cause)
研究者
相似试验
尚未招募
2 期
Treatment of Diabetic macular edema with intravitreal injection of antiangiogenic agents with or without DexamethasoneMacular EdemaC19.246.099DiabetesRBR-7468j4qniversidade Federal de Pernambuco
尚未招募
不适用
Changes in Retinal Blood Vessels seen in Diabetic Retinopathy and following its treatmentCTRI/2020/10/028396Sankara Eye Hospital Bangalore
已完成
不适用
Describing Patient With DME, Their Patient Journey and Disease ProgressionDiabetic Macular EdemaNCT05966753Boehringer Ingelheim221,004
招募中
1 期
Treatment of Diabetic Macular Edema with Intraocular Injection of DexamethasoneMacular EdemaH360DiabetesRBR-59phz5cniversidade Federal de Pernambuco
进行中（未招募）
1 期
Comparison of the efficacy of treatment of retinal macular inflammation due to diabetes with ozurdex or with ozurdex plus laser treatment in the area.Diabetic macular edemaMedDRA version: 19.0 Level: LLT Classification code 10057934 Term: Diabetic macular edema System Organ Class: 100000004853EUCTR2016-003870-41-ESFundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias30